Precision medicine after stem cell transplant
Treatments studied
Part of Blood & lymphatic clinical trials.
This study looks at a personalized (“precision”) approach for people who have received a stem cell transplant from a donor. It may help doctors better tailor care after transplant, especially for children.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a stem cell transplant from another person (a donor).
- Your age can be any (children and infants can join).
- You can still join if you are in another clinical trial already.
- You must weigh at least 5 kilograms (about 11 pounds).
- You must not have had a transplant using your own stem cells.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a personalized way to give a medicine that helps prevent complications after a stem cell transplant for blood cancers. The dose is adjusted based on your body to improve how well the transplant works.
This study looks at how certain proteins in the blood around the time of a stem cell transplant may differ based on your blood disease and the type of donor you have. It aims to help doctors understand how to better support patients during stem cell transplants.
This study collects medical information from people with certain non-cancer conditions who receive a stem cell transplant. It may help doctors better understand transplant outcomes and care, since the study focuses on data collection rather than adding new treatment.
This trial checks how certain blood “biomarkers” change after you receive donor stem cells to rebuild your blood and immune system. The goal is to learn whether these markers can better predict your immune recovery after transplant.
This study looks at a personalized lab test to detect small amounts of disease after a stem cell transplant and then decide what treatment comes next. It may help some people with certain bone-marrow diseases stay in remission while avoiding unnecessary treatment.
This trial uses precise, personalized approaches to manage heart transplant recipients. It involves taking a small heart muscle sample (a biopsy) to monitor for rejection or routine checks.
Hear when a new Haematopoietic Stem Cell Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.